SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-20-001085
Filing Date
2020-09-14
Accepted
2020-09-14 18:11:28
Documents
2
Period of Report
2020-09-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1753
2 houstonpoa_09142020.htm EX-24 7186
  Complete submission text file 0001123292-20-001085.txt   10314
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ARVINAS, INC., 5 SCIENCE PARK 395 WINCHESTER AVE. NEW HAVEN CT 06511
Business Address
Houston John G (Reporting) CIK: 0001753537 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 201174253